2014•Clinical TherapeuticsRequires access

Is Splenectomy Necessary for Immune Thrombocytopenic Purpura? The Role of Rituximab in Patients With Corticosteroid Resistance in a Single-Center Experience

Cheng Zhang, Huanfeng Liu, Xinghua Chen, Lei Gao, Li Gao, Yao Z. Liu, Peiyan Kong, Aihua Sun, Xi Zhang

Open publisher page 6 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Rituximab, Medicine, Splenectomy, Thrombocytopenic purpura, Corticosteroid, Adverse effect, Internal medicine, Refractory (planetary science)

Back to paper search Browse research topics Original source

Is Splenectomy Necessary for Immune Thrombocytopenic Purpura? The Role of Rituximab in Patients With Corticosteroid Resistance in a Single-Center Experience — Research Paper | ScholarLens